Qu Biologics Launches Treatment Trial for Crohn’s Disease
Canadian participants are being sought for a new Health Canada-approved clinical trial for the treatment of Crohn’s disease , the Vancouver-based biopharmaceutical company Qu Biologics announced today.
Categories: Uncategorized Tags: announced-today, are-being, biologics, clinical-trial, crohn, for-the, health, sought-for, treatment, vancouver, vancouver-based
Infectious Disease Specialist, Brad Spellberg, M.D., Joins Synthetic Biologics' Scientific Advisory Board
ROCKVILLE, Md., Feb. 26, 2013 /PRNewswire/ – Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of synthetic biologics and innovative medicines for serious infections and diseases, announced today …
Categories: Uncategorized Tags: and-diseases, and-innovative, biologics, medicines-for, mkt, nyse, serious-infections, synthetic-biologics
Lilly To Launch New Alzheimer's Drug Phase 3 Trial
Eli Lilly have just announced plans to carry out a new large scale trial of their new drug solanezumab for treatment of mild Alzheimer's disease. The company decided not to submit a Biologics License Application (BLA) in the U.S based on the poor data from the drug's past EXPEDITION studies. Instead, they have announced that they are going to conduct an additional Phase 3 study of solanezumab …
Categories: Uncategorized Tags: a-from-the, a-new-large, alzheimer, application, based-on-the, biologics, carry-out, data-from, for-treatment, from-the-drug, new-large, poor, the-poor, their-new
Synthetic Biologics to Acquire Clinical-Stage C. difficile Infectious Disease Program
ROCKVILLE, Md., Nov.
Categories: Uncategorized Tags: and-diseases, and-innovative, announced-today, biologics, medicines-for, mkt, nyse, serious-infections, syn, synthetic-biologics
Synthetic Biologics Completes $10.8 Million Private Placement Financing
ROCKVILLE, Md., Oct. 31, 2012 /PRNewswire/ – Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of synthetic biologics and innovative medicines for serious diseases and unmet medical needs, announced …
Categories: Uncategorized Tags: and-innovative, and-unmet, announced-, biologics, medical-needs, medicines-for, mkt, nyse, serious-diseases, syn, synthetic-biologics
MissionIR News – RTI Biologics Launches New Biologic Implant, BioReady™ DBM Putty
New implant is for use in sports medicine, orthopedic, and spine surgeriesAtlanta, Georgia (PRWEB) October 28, 2012 MissionIR would like to highlight RTI Biologics, Inc., a leading publicly traded provider of sterile biologic implants around the world. The company is at the forefront of tissue-based innovations that repair and support the natural healing of human bone and tissues. RTI continues …
Categories: Uncategorized Tags: a-leading-publicly, and-tissues-, biologics, continues-, human-bone, natural, october, sports-medicine, the-forefront, the-natural, world